CRTAM-CADM1 INTERACTION IN THE BIOLOGY OF GUT LYMPHOCYTES
CRTAM-CADM1 INTERACTION IN THE BIOLOGY OF GUT LYMPHOCYTES
批准号:
9253389
负责人:
MARCO COLONNA
金额:
$34.31万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-03-01 至 2019-02-28
关键词:
AntibioticsAntigensAutoimmunityBacteriaBindingBiologyCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCell Differentiation processCell LineCell TherapyCellsDependencyDiseaseEnsureEpigenetic ProcessEpithelial CellsGastrointestinal DiseasesGastrointestinal tract structureGene Expression ProfileGenerationsGenetic Predisposition to DiseaseGerm-FreeGrantGranzymeHistone DeacetylaseHistone Deacetylase InhibitorHomingHumanImmuneImmune responseImmune systemImmunityIndividualInflammatoryInflammatory Bowel DiseasesInflammatory disease of the intestineInterferon Type IIInterleukin-10Intestinal DiseasesIntestinal MucosaIntestinesInvestigationLymphocyteLyticMHC Class II GenesMediator of activation proteinMesenteryMucosal Immune ResponsesMucous MembraneMusParasitic infectionPathogenicityPlayPopulationRUNX3 geneRegulationRegulatory T-LymphocyteRoleStem cellsSurfaceSymbiosisT-LymphocyteTherapeuticToxoplasma gondiiToxoplasmosisVolatile Fatty AcidsWorkbaseclass-I restricted T cell-associated moleculecytotoxicexperimental studyfood antigengastrointestinalgastrointestinal infectiongut microbiotaimmune activationimmunoregulationinnovationintraepitheliallymph nodesmicrobialmicrobiotanovelperforinpreventpublic health relevanceresponsetargeted treatmenttranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): An inappropriate immune response towards microbial flora in genetically predisposed individuals results in inflammatory bowel disease (IBD). The pathogenic response in IBD is driven by CD4+TH17. Immunoregulatory mechanisms that prevent or counter IBD typically rely on Tregs and IL-10. However, recent studies have identified the involvement of intraepithelial CD4+CD8+T cells in the regulation of intestinal inflammation. Here, we have identified a novel molecular interaction between CRTAM on intestinal T cells and CADM1 on intestinal DC and demonstrated that this interaction is required for intraepithelial CD4+CD8+T cells in the steady-state and for TH17 responses during T. gondii parasitic infection. These results mandate further investigation of the impact of CRTAM-CADM1 interactions on intestinal immunity and their potential exploitation for IBD therapy. In Aim 1, we propose experiments to distinguish whether CRTAM-CADM1 interactions act: a) exclusively in the gut mucosa to facilitate the retention of CD4+T cells and CD4+CD8+ T cells, or b) in the mesenteric lymph nodes to promote priming of CD4+T cells and the acquisition of gut homing molecules. Aim 2 is based on the observation that CD4+CD8+ T cells are absent in germ-free mice, whereas short chain fatty acids (SCFA) induce their expansion. Thus, we will investigate the mechanisms by which the microbiota induces the differentiation of CD4+CD8+T cells and ask whether these mechanisms involve CRTAM-CADM1 interaction. CD4+CD8+T cells may require presentation of commensal antigens by intestinal CADM1+DCs. Alternatively, commensal microbiota may release metabolites that facilitate CD4+CD8+T cell differentiation, possibly by acting as histone deacetylase (HDAC) inhibitors that impact the epigenetics of CD4+CD8+T cell progenitors or CADM1+DCs. In Aim 3, we will explore the mechanisms for the CRTAM-CADM1 dependency of TH17 responses to T. gondii: we will determine whether TH17 cells detected during T. gondii infection are directed toward translocated commensals or are specific for T. gondii and whether CRTAM-CADM1 interactions impact TH17 response to commensals in general. Given the emerging importance of CD4+CD8+T cells in the regulation of intestinal immunity, the relevance of TH17 responses to autoimmunity and the need to manipulate these cells for therapy, this proposal to study CRTAM-CADM1 interactions embodies a new perspective in intestinal immunity that is highly innovative and relevant to IBD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mucosal Immune Defense Mechanisms of the Urinary Bladder
-
批准号:10587639
-
项目类别:
-
资助金额:$62.28万
-
财政年份:2023
-
负责人:MARCO COLONNA
-
依托单位:
Soluble TREM2 regulation of microglial function in Alzheimer disease
-
批准号:10432584
-
项目类别:
-
资助金额:$43.06万
-
财政年份:2022
-
负责人:MARCO COLONNA
-
依托单位:
Impact of polyamines on ILC3 function at steady state and in preclinical model of colitis
-
批准号:10528082
-
项目类别:
-
资助金额:$19.69万
-
财政年份:2022
-
负责人:MARCO COLONNA
-
依托单位:
The protein tyrosine kinase SYK drives innate immune responses against Alzheimer's Disease
-
批准号:10674689
-
项目类别:
-
资助金额:$59.72万
-
财政年份:2022
-
负责人:MARCO COLONNA
-
依托单位:
Impact of polyamines on ILC3 function at steady state and in preclinical model of colitis
-
批准号:10623342
-
项目类别:
-
资助金额:$23.38万
-
财政年份:2022
-
负责人:MARCO COLONNA
-
依托单位:
Ontogenetic niche of B cells at the CNS borders in homeostasis, aging and autoimmunity
-
批准号:10446266
-
项目类别:
-
资助金额:$62.45万
-
财政年份:2022
-
负责人:MARCO COLONNA
-
依托单位:
Ontogenetic niche of B cells at the CNS borders in homeostasis, aging and autoimmunity
-
批准号:10557870
-
项目类别:
-
资助金额:$59.89万
-
财政年份:2022
-
负责人:MARCO COLONNA
-
依托单位:
Targeting TREM2 to boost anti-cancer therapy
-
批准号:10477296
-
项目类别:
-
资助金额:$43.23万
-
财政年份:2021
-
负责人:MARCO COLONNA
-
依托单位:
MICROBIOTA-DEPENDENT CONTROL OF CLOSTRIDIUM DIFFICILE: THE ROLE OF ACETATE AND IL-22 BINDING PROTEIN
-
批准号:10321553
-
项目类别:
-
资助金额:$41.51万
-
财政年份:2021
-
负责人:MARCO COLONNA
-
依托单位:
Targeting TREM2 to boost anti-cancer therapy
-
批准号:10279674
-
项目类别:
-
资助金额:$41.62万
-
财政年份:2021
-
负责人:MARCO COLONNA
-
依托单位:
MICROBIOTA-DEPENDENT CONTROL OF CLOSTRIDIUM DIFFICILE: THE ROLE OF ACETATE AND IL-22 BINDING PROTEIN
-
批准号:10539270
-
项目类别:
-
资助金额:$41.03万
-
财政年份:2021
-
负责人:MARCO COLONNA
-
依托单位:
Targeting TREM2 to boost anti-cancer therapy
-
批准号:10689150
-
项目类别:
-
资助金额:$43.23万
-
财政年份:2021
-
负责人:MARCO COLONNA
-
依托单位:
The Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis
-
批准号:10265677
-
项目类别:
-
资助金额:$24.13万
-
财政年份:2020
-
负责人:MARCO COLONNA
-
依托单位:
Plasticity of Innate Lymphoid Cells: Mechanisms and Biological Impact
-
批准号:10597244
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2020
-
负责人:MARCO COLONNA
-
依托单位:
Plasticity of Innate Lymphoid Cells: Mechanisms and Biological Impact
-
批准号:10363734
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2020
-
负责人:MARCO COLONNA
-
依托单位:
The Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis
-
批准号:10219643
-
项目类别:
-
资助金额:$35.86万
-
财政年份:2020
-
负责人:MARCO COLONNA
-
依托单位:
Impact of Airway Epithelium on Innate and Adaptive Immunity in the Lung
-
批准号:10371236
-
项目类别:
-
资助金额:$33.39万
-
财政年份:2019
-
负责人:MARCO COLONNA
-
依托单位:
Impact of Airway Epithelium on Innate and Adaptive Immunity in the Lung
-
批准号:10579869
-
项目类别:
-
资助金额:$28.0万
-
财政年份:2019
-
负责人:MARCO COLONNA
-
依托单位:
Impact of Airway Epithelium on Innate and Adaptive Immunity in the Lung
-
批准号:10113529
-
项目类别:
-
资助金额:$37.16万
-
财政年份:2019
-
负责人:MARCO COLONNA
-
依托单位:
CIS-REGULATORY CIRCUITS FOR ILC FUNCTION AND PLASTICITY
-
批准号:10219921
-
项目类别:
-
资助金额:$65.0万
-
财政年份:2018
-
负责人:MARCO COLONNA
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: